Sim&Cure, a Montpellier, France-based medtech startup proving digital solutions to secure neurovascular treatment of cerebral aneurysm, raised €3M in funding.
The round was led by Elaia with participation from IT Translation.
The company will use the funds to continue to expand operations.
Founded in 2014 by Mathieu Sanchez (Previous Philips Healthcare R&D Engineer, PhD in biomechanics) and Vincent Costalat (MD, PhD, head of neuroradiology department at CHU Montpellier), Sim&Cure is a digital startup focused on improving neurovascular treatments of cerebral aneurysm with a proprietary software suite, which stimulates each size and type of device to provide essential information prior to the choice of sizing.
It has already been used to treat more than 1,500 patients in 250 hospitals across more than 25 countries. Players like Medtronic, Stryker, Cerenovus (J&J), Microvention (Terumo), Balt and Phenix integrated their devices into the device to offer a large medical device portfolio to physicians.
The company currently employs 18 people.